Research Article
Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer
Table 2
14F7 Mab immunostaining in colon cancer.
| | 14F7 Mab immunostaining () | Number (%) |
| | Staining intensity | | | Weak | 3 (6) | | Moderate | 13 (26) | | Strong | 34 (68) | | Staining extent (%) | | | −50% | 5 (10) | | 51–75% | 14 (28) | | +75% | 31 (62) | | Level of immunostaining | | | Low (IRS < 6) | 15 (30) | | High (IRS ≥ 6) | 35 (70) |
|
|
IRS: immunoreactive score.
|
